All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Jnana Therapeutics Inc., a Boston-based startup building a drug discovery platform targeting a family of proteins that serve as cellular "metabolic gates," has raised a $50 million series A financing backed by Polaris Partners, Avalon Ventures, Versant Ventures, Abbvie Ventures LLC and Pfizer Inc.